-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Gallinamide-A
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1208232-55-6.gif)
| Category | SARS-CoV |
| CAS | 1208232-55-6 |
| Description | Gallinamide A is a potent inhibitor of cathepsin L with an IC50 value of 17.6 pM. |
Product Information
| Synonyms | Gallinamide A|Symplostatin 4|1208232-55-6|[(2S)-1-[[(2S)-1-[[(E,2S)-5-[(2S)-3-methoxy-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-en-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl] (2S,3S)-2-(dimethylamino)-3-methylpentanoate|CHEMBL541700|DTXSID50153030|EX-A5200|BDBM50033762|HY-N10109|CS-0255808|[(1S)-1-[[(1S)-1-[[(E,1S)-4-[(2S)-3-methoxy-2-methyl-5-oxo-2H-pyrrol-1-yl]-1-methyl-4-oxo-but-2-enyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl] (2S,3S)-2-(dimethylamino)-3-methyl-pentanoate |
| Molecular Weight | 592.77 |
| Molecular Formula | C31H52N4O7 |
| Canonical SMILES | CCC(C)C(C(=O)OC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C=CC(=O)N1C(C(=CC1=O)OC)C)N(C)C |
| Boiling Point | 747.8±60.0 °C at 760 mmHg |
| Flash Point | 406.1±32.9 °C |
| Purity | ≥98% (HPLC) |
| Density | 1.1±0.1 g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1020 |
| Exact Mass | 592.38360001 |
| Index Of Refraction | 1.522 |
| Target | SARS-CoV |
| Vapor Pressure | 0.0±2.5 mmHg at 25°C |
| XLogP3-AA | 4.2 |
